Tari Leslie — SEC Form 4 filings

SEC reporting owner CIK 1870270. 5 Form 4 filings on record with FilingPulse; latest filed 2025-03-13.

Transaction summary — filings shown

Covers all 5 filings on record, filed 2024-03-12 to 2025-03-13. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.

By issuer — same filings

Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.

IssuerRole (as filed)FilingsPurchases (P)Sales (S)Other legs
Cidara Therapeutics, Inc. (CDTX)CHIEF SCIENTIFIC OFFICER53 legs · 23,711 sh · $63,6053

Form 4 filings — Tari Leslie

FiledFormIssuerReported transactionsSource
2025-03-134Cidara Therapeutics, Inc. (CDTX)Sale (S): 1,773 @ $21.96EDGAR
2024-10-024Cidara Therapeutics, Inc. (CDTX)Grant/award (A): 150,224 (derivative) @ $0EDGAR
2024-09-134Cidara Therapeutics, Inc. (CDTX)Sale (S): 909 @ $11.64EDGAR
2024-03-204Cidara Therapeutics, Inc. (CDTX)Grant/award (A): 111,250 @ $0 · Grant/award (A): 222,500 (derivative) @ $0EDGAR
2024-03-124Cidara Therapeutics, Inc. (CDTX)Sale (S): 21,029 @ $0.67EDGAR

FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.

Need this as JSON? GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1870270 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →